Bristol Myers Squibb Revenue 2006-2020 | BMY

Bristol Myers Squibb annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Bristol Myers Squibb revenue for the quarter ending December 31, 2020 was $11.068B, a 39.31% increase year-over-year.
  • Bristol Myers Squibb revenue for the twelve months ending December 31, 2020 was $42.518B, a 62.62% increase year-over-year.
  • Bristol Myers Squibb annual revenue for 2020 was $42.518B, a 62.62% increase from 2019.
  • Bristol Myers Squibb annual revenue for 2019 was $26.145B, a 15.89% increase from 2018.
  • Bristol Myers Squibb annual revenue for 2018 was $22.561B, a 8.59% increase from 2017.
Bristol Myers Squibb Annual Revenue
(Millions of US $)
2020 $42,518
2019 $26,145
2018 $22,561
2017 $20,776
2016 $19,427
2015 $16,560
2014 $15,879
2013 $16,385
2012 $17,621
2011 $21,244
2010 $19,484
2009 $18,808
2008 $17,715
2007 $15,617
2006 $16,208
2005 $18,605
Bristol Myers Squibb Quarterly Revenue
(Millions of US $)
2020-12-31 $11,068
2020-09-30 $10,540
2020-06-30 $10,129
2020-03-31 $10,781
2019-12-31 $7,945
2019-09-30 $6,007
2019-06-30 $6,273
2019-03-31 $5,920
2018-12-31 $5,973
2018-09-30 $5,691
2018-06-30 $5,704
2018-03-31 $5,193
2017-12-31 $5,449
2017-09-30 $5,254
2017-06-30 $5,144
2017-03-31 $4,929
2016-12-31 $5,243
2016-09-30 $4,922
2016-06-30 $4,871
2016-03-31 $4,391
2015-12-31 $4,287
2015-09-30 $4,069
2015-06-30 $4,163
2015-03-31 $4,041
2014-12-31 $4,258
2014-09-30 $3,921
2014-06-30 $3,889
2014-03-31 $3,811
2013-12-31 $4,441
2013-09-30 $4,065
2013-06-30 $4,048
2013-03-31 $3,831
2012-12-31 $4,191
2012-09-30 $3,736
2012-06-30 $4,443
2012-03-31 $5,251
2011-12-31 $5,454
2011-09-30 $5,345
2011-06-30 $5,434
2011-03-31 $5,011
2010-12-31 $5,111
2010-09-30 $4,798
2010-06-30 $4,768
2010-03-31 $4,807
2009-12-31 $5,033
2009-09-30 $4,788
2009-06-30 $4,665
2009-03-31 $4,322
2008-12-31 $2,367
2008-09-30 $5,254
2008-06-30 $5,203
2008-03-31 $4,891
2007-12-31 $2,228
2007-09-30 $4,601
2007-06-30 $4,471
2007-03-31 $4,317
2006-12-31 $2,507
2006-09-30 $4,154
2006-06-30 $4,871
2006-03-31 $4,676
2005-12-31 $4,417
2005-09-30 $4,767
2005-06-30 $4,889
2005-03-31 $4,532
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $139.134B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.408B 13.71
CSL (CSLLY) Australia $95.963B 0.00
Gilead Sciences (GILD) United States $78.709B 8.86
Illumina (ILMN) United States $65.051B 99.08
Moderna (MRNA) United States $58.715B 0.00
Vertex Pharmaceuticals (VRTX) United States $55.366B 23.53
Regeneron Pharmaceuticals (REGN) United States $48.551B 15.87
Biogen (BIIB) United States $42.237B 8.45
Alexion Pharmaceuticals (ALXN) United States $33.780B 13.15
BeiGene (BGNE) Cayman Islands $30.162B 0.00
Seagen (SGEN) United States $27.191B 46.61
BioNTech SE (BNTX) Germany $27.047B 0.00
Exact Sciences (EXAS) United States $22.202B 0.00
Genmab (GMAB) Denmark $22.076B 30.90
Genmab (GNMSF) Denmark $21.283B 5.04
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.393B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.292B 23.28
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Incyte (INCY) United States $17.247B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.151B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.071B 0.00
Guardant Health (GH) United States $14.941B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.842B 118.49
Bio-Techne Corp (TECH) United States $14.164B 81.12
Novavax (NVAX) United States $14.101B 0.00
QIAGEN (QGEN) Netherlands $11.465B 23.41
Repligen (RGEN) United States $11.342B 124.74
Mirati Therapeutics (MRTX) United States $9.835B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.601B 0.00
Ultragenyx Pharmaceutical (RARE) United States $9.122B 0.00
Ascendis Pharma (ASND) Denmark $8.475B 0.00
Acceleron Pharma (XLRN) United States $8.186B 0.00
Vir Biotechnology (VIR) United States $8.167B 0.00
Fate Therapeutics (FATE) United States $8.091B 0.00
Adaptive Biotechnologies (ADPT) United States $7.700B 0.00
Denali Therapeutics (DNLI) United States $7.555B 242.31
ACADIA Pharmaceuticals (ACAD) United States $7.521B 0.00
Exelixis (EXEL) United States $6.851B 62.74
Sarepta Therapeutics (SRPT) United States $6.727B 0.00
Twist Bioscience (TWST) United States $6.540B 0.00
Halozyme Therapeutics (HALO) United States $6.400B 52.57
NeoGenomics (NEO) United States $5.647B 726.57
Galapagos (GLPG) Belgium $5.569B 0.00
Blueprint Medicines (BPMC) United States $5.569B 18.34
Emergent Biosolutions (EBS) United States $5.178B 12.38
Beam Therapeutics (BEAM) United States $5.131B 0.00
Certara (CERT) United States $5.044B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.010B 15.76
Arena Pharmaceuticals (ARNA) United States $4.796B 0.00
China Biologic Products (CBPO) China $4.709B 30.52
SpringWorks Therapeutics (SWTX) United States $4.340B 0.00
I-Mab (IMAB) China $4.207B 0.00
Reata Pharmaceuticals (RETA) United States $4.203B 0.00
Berkeley Lights (BLI) United States $3.985B 0.00
Insmed (INSM) United States $3.785B 0.00
NantKwest (NK) United States $3.726B 0.00
Legend Biotech (LEGN) United States $3.628B 0.00
Arvinas (ARVN) United States $3.580B 0.00
Apellis Pharmaceuticals (APLS) United States $3.412B 0.00
Intellia Therapeutics (NTLA) United States $3.395B 0.00
MorphoSys AG (MOR) Germany $3.365B 121.81
Amicus Therapeutics (FOLD) United States $3.106B 0.00
Alkermes (ALKS) Ireland $3.096B 0.00
Viela Bio (VIE) United States $2.906B 0.00
Intra-Cellular Therapies (ITCI) United States $2.860B 0.00
Sorrento Therapeutics (SRNE) United States $2.837B 0.00
Editas Medicine (EDIT) United States $2.806B 0.00
Amarin (AMRN) Ireland $2.702B 0.00
Global Blood Therapeutics (GBT) United States $2.688B 0.00
PHARMA MAR SA (PHMMF) Spain $2.544B 0.00
Ligand Pharmaceuticals (LGND) United States $2.495B 47.24
Deciphera Pharmaceuticals (DCPH) United States $2.454B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.413B 19.97
Genetron Holdings (GTH) China $2.312B 0.00
Myriad Genetics (MYGN) United States $2.272B 0.00
Arcus Biosciences (RCUS) United States $2.224B 0.00
Vericel (VCEL) United States $2.186B 951.40
Inovio Pharmaceuticals (INO) United States $2.147B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.125B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.962B 0.00
Bluebird Bio (BLUE) United States $1.866B 0.00
Heska (HSKA) United States $1.801B 0.00
NGM Biopharmaceuticals (NGM) United States $1.772B 0.00
Pandion Therapeutics (PAND) United States $1.766B 0.00
Zymeworks (ZYME) Canada $1.729B 0.00
Seres Therapeutics (MCRB) United States $1.715B 0.00
Scholar Rock Holding (SRRK) United States $1.706B 0.00
Revance Therapeutics (RVNC) United States $1.687B 0.00
Frequency Therapeutics (FREQ) United States $1.672B 0.00
UniQure (QURE) Netherlands $1.646B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.617B 0.00
Sangamo Therapeutics (SGMO) United States $1.603B 0.00
Antibe Therapeutics (ATBPF) Canada $1.540B 0.00
Precigen (PGEN) United States $1.537B 0.00
Bionano Genomics (BNGO) United States $1.535B 0.00
Travere Therapeutics (TVTX) United States $1.516B 0.00
Castle Biosciences (CSTL) United States $1.501B 0.00
REGENXBIO (RGNX) United States $1.496B 0.00
Pliant Therapeutics (PLRX) United States $1.410B 0.00
Alector (ALEC) United States $1.407B 0.00
Cytokinetics (CYTK) United States $1.405B 0.00
Zealand Pharma (ZEAL) Denmark $1.380B 0.00
MannKind (MNKD) United States $1.305B 0.00
Nurix Therapeutics (NRIX) United States $1.300B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.260B 0.00
Codexis (CDXS) United States $1.259B 0.00
Mersana Therapeutics (MRSN) United States $1.258B 0.00
Adverum Biotechnologies (ADVM) United States $1.220B 0.00
Zealand Pharma (ZLDPF) Denmark $1.203B 0.00
Northwest Biotherapeutics (NWBO) United States $1.182B 0.00
ChromaDex (CDXC) United States $1.158B 0.00
Mesoblast (MESO) Australia $1.128B 0.00
Athenex (ATNX) United States $1.108B 0.00
Coherus BioSciences (CHRS) United States $1.099B 9.02
Celldex Therapeutics (CLDX) United States $1.088B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.086B 0.00
MiMedx (MDXG) United States $1.083B 0.00
Avid Bioservices (CDMO) United States $1.075B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.062B 45.00
Morphic Holding (MORF) United States $1.022B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.996B 0.00
Epizyme (EPZM) United States $0.983B 0.00
Cara Therapeutics (CARA) United States $0.960B 240.75
Syndax Pharmaceuticals (SNDX) United States $0.952B 0.00
G1 THERAPEUTICS (GTHX) United States $0.938B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.919B 0.00
Protagonist Therapeutics (PTGX) United States $0.918B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.906B 0.00
Prothena (PRTA) Ireland $0.902B 0.00
Dynavax Technologies (DVAX) United States $0.899B 0.00
Five Prime Therapeutics (FPRX) United States $0.878B 0.00
Cellectis S.A (CLLS) France $0.877B 0.00
Sutro Biopharma (STRO) United States $0.839B 0.00
Pharming Group (PHGUF) Netherlands $0.839B 22.33
VBI Vaccines (VBIV) United States $0.794B 0.00
Kadmon Holdings (KDMN) United States $0.789B 0.00
Agenus (AGEN) United States $0.778B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.760B 0.00
Cel-Sci (CVM) United States $0.744B 0.00
AnaptysBio (ANAB) United States $0.711B 0.00
Starpharma Holdings (SPHRY) Australia $0.690B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.675B 0.00
ALBIREO PHARMA (ALBO) United States $0.669B 0.00
Merus (MRUS) Netherlands $0.648B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Xenon Pharmaceuticals (XENE) Canada $0.634B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.623B 0.00
Compugen (CGEN) Israel $0.613B 0.00
DBV Technologies S.A (DBVT) France $0.589B 0.00
Precision BioSciences (DTIL) United States $0.584B 0.00
Curis (CRIS) United States $0.573B 0.00
MeiraGTx Holdings (MGTX) United States $0.570B 0.00
Geron (GERN) United States $0.562B 0.00
AC Immune SA (ACIU) Switzerland $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.531B 71.90
Bicycle Therapeutics (BCYC) United Kingdom $0.531B 0.00
Clovis Oncology (CLVS) United States $0.525B 0.00
Neoleukin Therapeutics (NLTX) United States $0.521B 0.00
Amryt Pharma (AMYT) United Kingdom $0.515B 0.00
CorMedix Inc (CRMD) United States $0.507B 0.00
AquaBounty Technologies (AQB) United States $0.506B 0.00
AMMO (POWW) United States $0.505B 0.00
Gritstone Oncology (GRTS) United States $0.501B 0.00
Spero Therapeutics (SPRO) United States $0.500B 0.00
Syros Pharmaceuticals (SYRS) United States $0.499B 0.00
Affimed (AFMD) Germany $0.474B 0.00
Selecta Biosciences (SELB) United States $0.462B 0.00
WAVE Life Sciences (WVE) Singapore $0.459B 0.00
BioDelivery Sciences (BDSI) United States $0.446B 21.00
Kala Pharmaceuticals (KALA) United States $0.434B 0.00
UROGEN PHARMA (URGN) United States $0.423B 0.00
Opthea (OPT) Australia $0.423B 0.00
Puma Biotechnology (PBYI) United States $0.419B 0.00
Athersys (ATHX) United States $0.411B 0.00
Verastem (VSTM) United States $0.401B 0.00
Cue Biopharma (CUE) United States $0.401B 0.00
IBio (IBIO) United States $0.400B 0.00
XOMA (XOMA) United States $0.399B 0.00
Oncobiologics (OTLK) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.366B 9.31
Nabriva Therapeutics AG (NBRV) Ireland $0.363B 0.00
CytomX Therapeutics (CTMX) United States $0.363B 0.00
Forte Biosciences (FBRX) United States $0.361B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.354B 0.00
Innate Pharma S.A (IPHA) France $0.349B 0.00
Fortress Biotech (FBIO) United States $0.348B 0.00
Cardiff Oncology (CRDF) United States $0.344B 0.00
Trevena (TRVN) United States $0.344B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.343B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.342B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.335B 0.00
Arbutus Biopharma (ABUS) United States $0.324B 0.00
NextCure (NXTC) United States $0.319B 0.00
Bellus Health (BLU) Canada $0.307B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.301B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Kamada (KMDA) Israel $0.279B 16.05
Cerecor (CERC) United States $0.273B 0.00
HOOKIPA Pharma (HOOK) United States $0.255B 0.00
OSMOTICA PHARM (OSMT) United States $0.248B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 0.00
TELA Bio (TELA) United States $0.236B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.235B 0.00
Voyager Therapeutics (VYGR) United States $0.233B 6.56
Aptinyx (APTX) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Applied Genetic Technologies (AGTC) United States $0.226B 0.00
ADMA Biologics Inc (ADMA) United States $0.222B 0.00
Checkpoint Therapeutics (CKPT) United States $0.222B 0.00
Strongbridge Biopharma (SBBP) United States $0.216B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.208B 0.00
VolitionRX (VNRX) United States $0.203B 0.00
Eton Pharmaceuticals (ETON) United States $0.200B 0.00
Pluristem Therapeutics (PSTI) Israel $0.199B 0.00
Exicure (XCUR) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
GENFIT S.A (GNFT) France $0.196B 0.00
Palatin Technologies (PTN) United States $0.189B 0.00
VTv Therapeutics (VTVT) United States $0.188B 0.00
Nicox SA (NICXF) France $0.185B 0.00
Kindred Biosciences (KIN) United States $0.181B 0.00
Protalix BioTherapeutics (PLX) Israel $0.177B 0.00
DiaMedica Therapeutics (DMAC) United States $0.173B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.169B 0.00
Orgenesis (ORGS) United States $0.166B 344.50
Seelos Therapeutics (SEEL) United States $0.163B 0.00
Cogent Biosciences (COGT) United States $0.159B 0.00
Clearside Biomedical (CLSD) United States $0.157B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.157B 0.00
Evogene (EVGN) Israel $0.156B 0.00
Dyadic (DYAI) United States $0.151B 0.00
Biofrontera AG (BFRA) Germany $0.150B 0.00
Idera Pharmaceuticals (IDRA) United States $0.150B 0.00
Liminal BioSciences (LMNL) Canada $0.145B 0.00
Enzo Biochem (ENZ) United States $0.141B 0.00
Aytu Bioscience (AYTU) United States $0.141B 0.00
Aptevo Therapeutics (APVO) United States $0.138B 0.00
Catalyst Biosciences (CBIO) United States $0.135B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.135B 0.00
Liquidia Technologies (LQDA) United States $0.132B 0.00
Synlogic (SYBX) United States $0.132B 0.00
Prima BioMed (IMMP) Australia $0.131B 0.00
Cyclerion Therapeutics (CYCN) United States $0.130B 0.00
TRACON Pharmaceuticals (TCON) United States $0.123B 0.00
Beyond Air (XAIR) United States $0.123B 0.00
CytRx (CYTR) United States $0.121B 0.00
Lumos Pharma (LUMO) United States $0.119B 0.00
ARAVIVE, INC (ARAV) United States $0.114B 0.00
PHASEBIO PHARMA (PHAS) United States $0.114B 0.00
Cocrystal Pharma (COCP) United States $0.112B 0.00
Celyad SA (CYAD) Belgium $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.107B 0.00
Ecology Coatings (ABVC) United States $0.102B 0.00
AIkido Pharma (AIKI) United States $0.101B 0.00
Advaxis (ADXS) United States $0.099B 0.00
Novogen (KZIA) Australia $0.098B 0.00
Stealth BioTherapeutics (MITO) United States $0.095B 42.75
Adocia (ADOCY) France $0.092B 0.00
Organovo Holdings (ONVO) United States $0.091B 0.00
Vascular Biogenics (VBLT) Israel $0.087B 0.00
Windtree Therapeutics (WINT) United States $0.085B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.083B 0.00
AEterna Zentaris (AEZS) United States $0.083B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
Celsion (CLSN) United States $0.082B 0.00
Purple Biotech (PPBT) Israel $0.076B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.075B 0.00
AnPac Bio-Medical Science (ANPC) China $0.075B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
Cleveland BioLabs (CBLI) United States $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.069B 0.00
Genetic Technologies (GENE) Australia $0.066B 0.00
ARIDIS PHARMACT (ARDS) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
Enveric Biosciences (ENVB) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Happiness Biotech Group (HAPP) China $0.053B 0.00
Soligenix (SNGX) United States $0.053B 0.00
BioCardia (BCDA) United States $0.050B 0.00
Acorda Therapeutics (ACOR) United States $0.048B 0.00
ATyr Pharma (LIFE) United States $0.046B 0.00
Yumanity Therapeutics (YMTX) United States $0.046B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.042B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.039B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.031B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.030B 0.00
ThermoGenesis Holdings (THMO) United States $0.024B 0.00
Seneca Biopharma (SNCA) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
GeoVax Labs (GOVX) United States $0.024B 0.00
Timber Pharmaceuticals (TMBR) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.014B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00